Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Dynavax Technologies Corporation (DVAX)

« Back to company index

DVAX Chatter Timeline

Stock Ticker for DVAX

Most Active Tweeters for DVAX

UserTweets
@Tickeron 12
@AmericanBanking 5
@Gambiste1 4
@bbnsnews 3
@TheMarketsDaily 3

Recent Tweets for DVAX

marketdollqueen @marketdollqueen
$DVAX cmon...let it go already...don’t be squashing all the momo....
December 6th 2019, 1:12pm
AmericanBanking @AmericanBanking
Dynavax Technologies $DVAX Earns “Buy” Rating from William Blair https://t.co/0CT2tVwkFJ #stocks
December 6th 2019, 12:12pm
AmericanBanking @AmericanBanking
William Blair Equities Analysts Decrease Earnings Estimates for Dynavax Technologies Co. $DVAX https://t.co/lYH3sCha8l #stocks
December 6th 2019, 7:12am
bbnsnews @bbnsnews
Dynavax Technologies Co. Expected to Post FY2020 Earnings of -$1.10 Per Share $DVAX https://t.co/wt7Bt5L936
December 6th 2019, 7:12am
dakotafinancial @dakotafinancial
Dynavax Technologies $DVAX Stock Rating Upgraded by Zacks Investment Research https://t.co/PI8oy8mIKD
December 6th 2019, 3:12am
Tickeron @Tickeron
$DVAX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/3r4ZT0dLNL
December 6th 2019, 1:12am
EnterpriseLeade @EnterpriseLeade
Dynavax Technologies Co. $DVAX Given Average Rating of “Buy” by Brokerages https://t.co/cv6NvBQlpA
December 5th 2019, 11:12pm
TheMarketsDaily @TheMarketsDaily
Dynavax Technologies Co. $DVAX Given Consensus Rating of “Buy” by Brokerages https://t.co/ds6gIB4ZWV
December 5th 2019, 11:12pm
MaisaCorp @MaisaCorp
$DVAX it has partnered with Albertsons Companies to provide Heplisav-B, a hepatitis B vaccine, to patients with a s… https://t.co/CJBflUS3w9
December 5th 2019, 7:12pm
newsfilterio @newsfilterio
Dynavax up 4% premarket on Albertsons' deal in hepatitis B $DVAX https://t.co/7qn9DHIyOT
December 5th 2019, 1:12pm
TranscriptDaily @TranscriptDaily
Dynavax Technologies $DVAX Upgraded to “Hold” by Zacks Investment Research https://t.co/BSeCx8tU8c
December 5th 2019, 12:12pm
EnterpriseLeade @EnterpriseLeade
Dynavax Technologies $DVAX Lifted to Hold at Zacks Investment Research https://t.co/D3HIb7YgWW
December 5th 2019, 12:12pm
Gambiste1 @Gambiste1
RT @mb_willoughby: $dvax nice daily chart looking to breakout https://t.co/2IncDmnEbz
December 5th 2019, 10:12am
mb_willoughby @mb_willoughby
$dvax nice daily chart looking to breakout https://t.co/2IncDmnEbz
December 5th 2019, 10:12am
StckPro @StckPro
$DVAX NEW ARTICLE : Dynavax up 4% premarket on Albertsons' deal in hepatitis B https://t.co/UL3DqCAqoj Get all the… https://t.co/qnvvlLPSR1
December 5th 2019, 8:12am
MarketCurrents @MarketCurrents
$DVAX - Dynavax up 4% premarket on Albertsons' deal in hepatitis B https://t.co/fSSVgTUO93
December 5th 2019, 8:12am
bbnsnews @bbnsnews
Brokerages Expect Dynavax Technologies Co. $DVAX Will Announce Quarterly Sales of $11.92 Million https://t.co/7J79OCBRLS
December 5th 2019, 12:12am
ConsumerFeed @ConsumerFeed
$11.92 Million in Sales Expected for Dynavax Technologies Co. $DVAX This Quarter https://t.co/P16iELE8lg
December 5th 2019, 12:12am
Tickeron @Tickeron
$DVAX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/vkFsPNGzQL
December 4th 2019, 10:12pm
MaisaCorp @MaisaCorp
$DVAX Announces Heplisav-B Post-Marketing Requirement Interim Report Completed
December 3rd 2019, 6:12pm
TranscriptDaily @TranscriptDaily
Dynavax Technologies Co. $DVAX Receives $16.50 Consensus PT from Analysts https://t.co/qXqOfaJ3IV
December 3rd 2019, 2:12pm
stocknewstimes @stocknewstimes
Dynavax Technologies Co. $DVAX Receives $16.50 Average Price Target from Brokerages https://t.co/jhvHX9phJE
December 3rd 2019, 2:12pm
JUDDLILIHA @JUDDLILIHA
RT @bradloncar: $DVAX finished up an interim analysis of the post-marketing follow-up of HEPLISAV-B and says there were no imbalances in AM…
December 3rd 2019, 12:12pm
Briefingcom @Briefingcom
$DVAX: Dynavax files report on cumulative analysis of post-marketing study of HEPLISAV-B for review by the FDA https://t.co/c6ns2IO271
December 3rd 2019, 9:12am
gregorypozo @gregorypozo
RT @OpenOutcrier: $DVAX (+3.1% pre) Dynavax Announces HEPLISAV-B Post-Marketing Requirement Interim Report Completed - GN https://t.co/9eU…
December 3rd 2019, 9:12am
OpenOutcrier @OpenOutcrier
$DVAX (+3.1% pre) Dynavax Announces HEPLISAV-B Post-Marketing Requirement Interim Report Completed - GN https://t.co/9eUgUV1iO9
December 3rd 2019, 8:12am
AlpBugraBasat @AlpBugraBasat
@avidresearch In particular, vaccine R&D is more of a big pharm business these days. $DVAX is a unique example in that.
December 3rd 2019, 7:12am
Gambiste1 @Gambiste1
RT @otcdynamics: $DVAX Dynavax Announces HEPLISAV-B Post-Marketing Requirement Interim Report Completed https://t.co/TmkcaHC3VU
December 3rd 2019, 7:12am
Gambiste1 @Gambiste1
RT @avidresearch: @AlpBugraBasat Poor $DVAX used every ounce of their energy to get Hep B vaccine approved. agree with what u said, I.e. st…
December 3rd 2019, 7:12am
otcdynamics @otcdynamics
$DVAX Dynavax Announces HEPLISAV-B Post-Marketing Requirement Interim Report Completed https://t.co/TmkcaHC3VU
December 3rd 2019, 7:12am
bradloncar @bradloncar
$DVAX finished up an interim analysis of the post-marketing follow-up of HEPLISAV-B and says there were no imbalances in AMI events.
December 3rd 2019, 7:12am
avidresearch @avidresearch
@AlpBugraBasat Poor $DVAX used every ounce of their energy to get Hep B vaccine approved. agree with what u said, I… https://t.co/pl9anxerAs
December 3rd 2019, 6:12am
Tickeron @Tickeron
$DVAX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/nKAJjxkdjZ
December 3rd 2019, 12:12am
dispatchtribune @dispatchtribune
$11.92 Million in Sales Expected for Dynavax Technologies Co. $DVAX This Quarter https://t.co/ygKaQ4VUOM
December 2nd 2019, 9:12pm
Tickeron @Tickeron
$DVAX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/tkGP2Ma5nE
December 2nd 2019, 4:12am
dakotafinancial @dakotafinancial
Dynavax Technologies $DVAX Lifted to “Hold” at Zacks Investment Research https://t.co/JdQ4euo68C
December 2nd 2019, 3:12am
ChartMill @ChartMill
$DVAX has an average volume of 1117020. This is a good sign as it is always nice to have a liquid stock.… https://t.co/YuvIubUbGy
December 1st 2019, 2:12pm
WeekHerald @WeekHerald
Zacks Investment Research Upgrades Dynavax Technologies $DVAX to Hold https://t.co/eAbdXGJKx8
December 1st 2019, 7:12am
OlympiaReport @OlympiaReport
Dynavax Technologies $DVAX Raised to “Hold” at Zacks Investment Research https://t.co/HTVk3SitnR
December 1st 2019, 7:12am
Tickeron @Tickeron
$DVAX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/5Co4zi3acw
December 1st 2019, 6:12am
bbnsnews @bbnsnews
Dynavax Technologies $DVAX Upgraded at Zacks Investment Research https://t.co/WPCRZEDSmc
November 30th 2019, 1:11am
Tickeron @Tickeron
$DVAX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/1RWpKGiFga
November 30th 2019, 12:11am
Tickeron @Tickeron
$DVAX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/ZJvBcdrDPM
November 28th 2019, 11:11pm
TranscriptDaily @TranscriptDaily
Zacks Investment Research Upgrades Dynavax Technologies $DVAX to “Hold” https://t.co/GnA3pGioNO
November 28th 2019, 10:11pm
TheMarketsDaily @TheMarketsDaily
Zacks Investment Research Upgrades Dynavax Technologies $DVAX to “Hold” https://t.co/Yr3TwEj8Cw
November 28th 2019, 10:11pm
stocknewstimes @stocknewstimes
Zacks Investment Research Upgrades Dynavax Technologies $DVAX to “Hold” https://t.co/NPcfwR85T2
November 28th 2019, 9:11pm
ThisLincolnian @ThisLincolnian
Zacks: Analysts Expect Dynavax Technologies Co. $DVAX to Announce -$0.34 Earnings Per Share https://t.co/xWtIKbVlIg
November 28th 2019, 9:11am
ThisLincolnian @ThisLincolnian
Dynavax Technologies Co. $DVAX Receives Average Recommendation of “Buy” from Brokerages https://t.co/WLjLAzTfrB
November 28th 2019, 4:11am
AmericanBanking @AmericanBanking
Dynavax Technologies Co. $DVAX Receives Average Recommendation of “Buy” from Brokerages https://t.co/pidBUy5DCw #stocks
November 28th 2019, 4:11am
Tickeron @Tickeron
$DVAX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/npp8P1gB4N
November 28th 2019, 12:11am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.